| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 24,621,829 | 18,280,900 | 13,582,865 | | Cost of Revenue | 16,493,655 | 9,274,501 | 5,646,298 | | | Gross Profit | 8,128,174 | 9,006,399 | 7,936,567 | | | Operating Expenses | | Research Development | 818 | 34,660 |
-
| | Selling General and Administrative | 3,870,559 | 4,790,161 | 3,990,165 | | Non Recurring | 39,278 | 76,455 | 37,756 | | Others | 910,768 | 929,693 | 625,555 | | | | Total Operating Expenses | 4,821,424 | 5,830,968 |
-
| | | | Operating Income or Loss | 3,306,750 | 3,175,431 | 3,283,091 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (750,381) | 215,093 | (8,581) | | Earnings Before Interest And Taxes | 2,556,369 | 3,390,524 | 3,274,510 | | Interest Expense |
-
|
-
| 18,020 | | Income Before Tax | 2,556,369 | 3,390,524 | 3,256,490 | | Income Tax Expense | 813,390 | 518,875 | 716,514 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,742,979 | 2,871,650 | 2,539,976 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| (3,432) | | Other Items |
-
|
-
|
-
| | | | Net Income | 1,742,979 | 2,871,650 | 2,536,544 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,742,979 | $2,871,650 | $2,536,544 |
|
1.48% Nasdaq 
Income Statement
